Literature DB >> 30236952

Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates.

Jennifer K Bender1, Carola Fleige2, Dominik Lange2, Ingo Klare2, Guido Werner2.   

Abstract

The number of linezolid-resistant Enterococcus spp. isolates received by the National Reference Centre for Staphylococci and Enterococci in Germany has been increasing since 2011. Although the majority are E. faecium, clinical linezolid-resistant E. faecalis have also been isolated. With respect to the newly discovered linezolid resistance protein OptrA, the authors conducted a retrospective polymerase chain reaction screening of 698 linezolid-resistant enterococcus clinical isolates. That yielded 43 optrA-positive strains, of which a subset was analysed by whole-genome sequencing in order to infer linezolid resistance-associated mechanisms and phylogenetic relatedness, and to disclose optrA genetic environments. Multiple optrA variants were detected. The originally described variant from China (optrAWT) was the only variant shared between the two Enterococcus spp.; however, distinct optrAWT loci were detected for E. faecium and E. faecalis. Generally, optrA localized to a plethora of genetic backgrounds that differed even for identical optrA variants. This suggests transmission of a mobile genetic element harbouring the resistance locus. Additionally, identical optrA variants detected on presumably identical plasmids, that were present in unrelated strains, indicates dissemination of the entire optrA-containing plasmid. In accordance, in vitro conjugation experiments verified transfer of optrA plasmids between enterococci of the same and of different species. In conclusion, multiple optrA variants located on distinct plasmids and mobile genetic elements with the potential for conjugative transfer are supposedly causative for the emergence of optrA-positive enterococci. Hence, rapid dissemination of the resistance determinant under selective pressure imposed by extensive use of last-resort antibiotics in clinical settings could be expected.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Enterococcus spp.; Linezolid resistance; Plasmid background; Plasmid transfer; optrA; optrA variants

Mesh:

Substances:

Year:  2018        PMID: 30236952     DOI: 10.1016/j.ijantimicag.2018.09.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.

Authors:  Lara M Almeida; François Lebreton; Anthony Gaca; Paulo M Bispo; Jose T Saavedra; Rodrigo N Calumby; Luciano M Grillo; Ticiano G Nascimento; Pedro H Filsner; Andrea M Moreno; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

2.  Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.

Authors:  Sarah A Egan; Anna C Shore; Brian O'Connell; Grainne I Brennan; David C Coleman
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

3.  Complete Genome Sequence and Characterization of Linezolid-Resistant Enterococcus faecalis Clinical Isolate KUB3006 Carrying a cfr(B)-Transposon on Its Chromosome and optrA-Plasmid.

Authors:  Makoto Kuroda; Tsuyoshi Sekizuka; Hidehito Matsui; Katsunori Suzuki; Hiroyuki Seki; Mitsumasa Saito; Hideaki Hanaki
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

Review 4.  Genomics of vancomycin-resistant Enterococcus faecium.

Authors:  Claire Gorrie; Charlie Higgs; Glen Carter; Timothy P Stinear; Benjamin Howden
Journal:  Microb Genom       Date:  2019-07-22

5.  Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland -commensals or hospital-adapted pathogens?

Authors:  Beata Krawczyk; Magdalena Wysocka; Roman Kotłowski; Marek Bronk; Michał Michalik; Alfred Samet
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

6.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

7.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

8.  Comparative genomics of global optrA-carrying Enterococcus faecalis uncovers a common chromosomal hotspot for optrA acquisition within a diversity of core and accessory genomes.

Authors:  Ana R Freitas; Ana P Tedim; Carla Novais; Val F Lanza; Luísa Peixe
Journal:  Microb Genom       Date:  2020-03-09

9.  Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital.

Authors:  Kuenyoul Park; Yun Sil Jeong; Jeonghyun Chang; Heungsup Sung; Mi Na Kim
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

10.  ResFinder 4.0 for predictions of phenotypes from genotypes.

Authors:  Valeria Bortolaia; Rolf S Kaas; Etienne Ruppe; Marilyn C Roberts; Stefan Schwarz; Vincent Cattoir; Alain Philippon; Rosa L Allesoe; Ana Rita Rebelo; Alfred Ferrer Florensa; Linda Fagelhauer; Trinad Chakraborty; Bernd Neumann; Guido Werner; Jennifer K Bender; Kerstin Stingl; Minh Nguyen; Jasmine Coppens; Basil Britto Xavier; Surbhi Malhotra-Kumar; Henrik Westh; Mette Pinholt; Muna F Anjum; Nicholas A Duggett; Isabelle Kempf; Suvi Nykäsenoja; Satu Olkkola; Kinga Wieczorek; Ana Amaro; Lurdes Clemente; Joël Mossong; Serge Losch; Catherine Ragimbeau; Ole Lund; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2020-12-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.